STOCK TITAN

Insider at VRTX (VRTX) plans sale of 609 vested shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An affiliate of VRTX, identified as Ourania Tatsis, has filed a notice to sell 609 shares of common stock through Fidelity Brokerage Services on NASDAQ around 02/17/2026. These shares were acquired on 02/13/2026 via restricted stock vesting as compensation from the issuer.

The filing also lists recent sales over the prior three months. On 12/03/2025 and 01/07/2026, Tatsis sold 4,500 common shares each, with gross proceeds of 2024955.40 and 2137455.00. Additional sales on 02/11/2026 and 02/13/2026 covered 466 and 1,500 shares, with proceeds of 214560.38 and 749992.02.

Positive

  • None.

Negative

  • None.

Insights

Routine insider share sale plan disclosed with prior sales detail.

The notice shows that an insider associated with VRTX, Ourania Tatsis, plans to sell 609 common shares acquired from restricted stock vesting. The sale is to be executed through Fidelity Brokerage Services on NASDAQ around 02/17/2026, indicating a standard liquidity transaction.

The document also outlines several prior sales over the last three months, including multiple 4,500-share transactions and smaller blocks, with specified gross proceeds. This pattern provides transparency into recent insider activity but, by itself, does not quantify any broader impact on the company’s operations or financial condition.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What insider sale is disclosed for VRTX in this notice?

The notice shows insider Ourania Tatsis intends to sell 609 shares of VRTX common stock. The shares will be sold through Fidelity Brokerage Services on NASDAQ, with an approximate sale date of 02/17/2026, following vesting of restricted stock on 02/13/2026.

How did the VRTX insider acquire the 609 shares being sold?

The 609 VRTX common shares being sold were acquired on 02/13/2026 through restricted stock vesting. The filing describes the nature of the acquisition transaction as compensation from the issuer, meaning the shares came from an equity award rather than an open-market purchase.

Which broker and exchange will handle the new VRTX share sale?

The planned sale of 609 VRTX common shares will be executed through Fidelity Brokerage Services LLC. The filing lists NASDAQ as the securities exchange where the transaction is expected to occur, with an approximate sale date of 02/17/2026 for the planned trade.

What VRTX insider stock sales occurred in the last three months?

The filing reports several recent VRTX sales by Ourania Tatsis: 4,500 common shares on 12/03/2025, another 4,500 on 01/07/2026, 466 on 02/11/2026, and 1,500 on 02/13/2026, each with clearly stated gross proceeds figures in the disclosure tables.

What gross proceeds did the VRTX insider receive from recent sales?

The disclosure lists gross proceeds of 2024955.40 from 4,500 shares sold on 12/03/2025 and 2137455.00 from 4,500 shares on 01/07/2026. Additional sales on 02/11/2026 and 02/13/2026 generated 214560.38 and 749992.02, respectively, from smaller share blocks.

What representation does the VRTX insider make about non-public information?

By signing the notice, the insider represents that they do not know any material adverse information about VRTX’s current or prospective operations that has not been publicly disclosed. This representation is required for sales relying on Rule 144 and helps support fair disclosure standards.
Vertex Pharmaceuticals Inc

NASDAQ:VRTX

VRTX Rankings

VRTX Latest News

VRTX Latest SEC Filings

VRTX Stock Data

124.83B
263.31M
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON